Kenneth Hoberman
CIK 1573722 · Chief Operating Officer · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$18.68M
Companies
3
Total Filings
55
Lifetime Open-Market Net
-$5.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 6
55 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-05 | NVCT | Grant (A) | — | $0 | EDGAR |
| 2021-06-22 | TGTX | Grant (A) | +20,000 | $0 | EDGAR |
| 2020-06-24 | TGTX | Grant (A) | +15,000 | $0 | EDGAR |
| 2020-06-10 | STEMLINE THERAPEUTICS INC (STML) Delisted | Mixed | −774,352 | $0 | EDGAR |
| 2020-03-13 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −26,191 | -$130.2K | EDGAR |
| 2020-02-28 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −11,547 | -$74.1K | EDGAR |
| 2020-02-14 | STEMLINE THERAPEUTICS INC (STML) Delisted | Grant (A) | +208,417 | $0 | EDGAR |
| 2020-01-24 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −22,139 | -$155.4K | EDGAR |
| 2020-01-10 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −13,228 | -$137.2K | EDGAR |
| 2020-01-03 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −46,312 | -$502.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.